HM
ARCT icon

HealthCor Management’s Arcturus Therapeutics ARCT Stock Holding History

HealthCor Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,594,452
Closed -$68.4M – 59
2020
Q3 		$68.4M Buy
1,594,452
+1,500,252
+1,593% +$74.5M 2.74% 17
2020
Q2 		$4.4M Buy
+94,200
New +$3.25M 0.18% 43

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return

HealthCor Management's ARCT Position: Q4 2020 in Review

HealthCor Management sold out of Arcturus Therapeutics (ARCT) in Q4 2020, closing a stake of 1,594,452 shares — an estimated $68.4M sold.

HealthCor Management first reported a position in ARCT in Q2 2020 and held it in 2 quarters. The position peaked at $68.4M in Q3 2020. 135 funds tracked by Wall St. Rank hold ARCT as of Q4 2020.

  • HealthCor Management reported no remaining Arcturus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • HealthCor Management sold 1,594,452 Arcturus Therapeutics shares in Q4 2020, an estimated $68.4M.
  • HealthCor Management first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 2 quarters.
  • HealthCor Management's Arcturus Therapeutics position peaked at $68.4M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2020.

Based on HealthCor Management's 13F filing for Q4 2020, filed 16 Feb 2021.